These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy? Mesraoua B; Perucca E; Tomson T; Asadi-Pooya AA Epilepsy Behav; 2023 May; 142():109205. PubMed ID: 37031583 [TBL] [Abstract][Full Text] [Related]
24. Comparison of Long-Term Outcomes of Monotherapy and Polytherapy in Seizure-Free Patients With Epilepsy Following Antiseizure Medication Withdrawal. Wang Y; Xia L; Li R; Li Y; Li J; Zhou Q; Pan S Front Neurol; 2021; 12():669703. PubMed ID: 34108931 [No Abstract] [Full Text] [Related]
27. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Marson AG; Tudur Smith C Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037 [TBL] [Abstract][Full Text] [Related]
28. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures. Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010 [TBL] [Abstract][Full Text] [Related]
29. Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM). Husni RE; Ngo LY; Senokuchi H; Patten A; Hiramatsu H; Watanabe K; Yamamoto T Epilepsia Open; 2022 Mar; 7(1):59-66. PubMed ID: 34657389 [TBL] [Abstract][Full Text] [Related]
30. Patterns of antiseizure medication utilization in the Human Epilepsy Project. Fox J; Barnard S; Agashe SH; Holmes MG; Gidal B; Klein P; Abou-Khalil BW; French J; Epilepsia; 2023 Dec; 64(12):3196-3204. PubMed ID: 37846772 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of antiseizure medication in post-stroke epilepsy. Winter Y; Uphaus T; Sandner K; Klimpe S; Stuckrad-Barre SV; Groppa S Seizure; 2022 Aug; 100():109-114. PubMed ID: 35834881 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study. van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF Neurology; 2023 Apr; 100(14):e1488-e1496. PubMed ID: 36754633 [TBL] [Abstract][Full Text] [Related]
33. Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures. Glass HC; Soul JS; Chang T; Wusthoff CJ; Chu CJ; Massey SL; Abend NS; Lemmon M; Thomas C; Numis AL; Guillet R; Sturza J; McNamara NA; Rogers EE; Franck LS; McCulloch CE; Shellhaas RA JAMA Neurol; 2021 Jul; 78(7):817-825. PubMed ID: 34028496 [TBL] [Abstract][Full Text] [Related]
34. Adolescent-Onset Epilepsy: Clinical Features and Predictive Factors for First-Year Seizure Freedom. Kim JS; Woo H; Lee JH; Kim WS Neuropediatrics; 2024 Aug; 55(4):232-240. PubMed ID: 37995745 [TBL] [Abstract][Full Text] [Related]
35. Patterns of Antiseizure Medication Use Following Meningioma Resection: A Single-Institution Experience. Ellis EM; Drumm MR; Rai S; Huang J; Tate MC; Magill ST; Templer JW World Neurosurg; 2024 Jan; 181():e392-e398. PubMed ID: 37852471 [TBL] [Abstract][Full Text] [Related]
36. Variation in seizure risk increases from antiseizure medication withdrawal among patients with well-controlled epilepsy: A pooled analysis. Terman SW; Slinger G; Koek A; Skvarce J; Springer MV; Ziobro JM; Burke JF; Otte WM; Thijs RD; Lossius MI; Marson AG; Bonnett LJ; Braun KPJ Epilepsia Open; 2024 Feb; 9(1):333-344. PubMed ID: 38071463 [TBL] [Abstract][Full Text] [Related]